ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
about
Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.Riluzole does not improve lifespan or motor function in three ALS mouse models.Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells.ALSUntangled 42: Elysium health's "basis".Incorporating upper motor neuron health in ALS drug discovery.Open Science Meets Stem Cells: A New Drug Discovery Approach for Neurodegenerative Disorders.CNS inflammation and neurodegeneration.A Possible Role for Platelet-Activating Factor Receptor in Amyotrophic Lateral Sclerosis Treatment.Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis.Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis.Profile of Arachidonic Acid-Derived Inflammatory Markers and Its Modulation by Nitro-Oleic Acid in an Inherited Model of Amyotrophic Lateral Sclerosis.RNA-Targeted Therapies and Amyotrophic Lateral Sclerosis.Patient-Derived iPSCs and iNs-Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases.The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials.Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1G93A and NSG animal models.Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALSNuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosisMaximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current PerspectivesAnalysis of riluzole’s profile of use in a Central Hospital in Lisbon
P2860
Q41488070-BB39FE1E-A911-439C-92ED-8182CAA88BADQ47152662-FE805D9B-2284-4E55-B886-2F6F4A7A2D79Q47341875-1E53ABC3-8D6B-436C-8C0A-0E7F4C9F82C8Q47868914-4BE9CD0C-A2DA-44CC-9581-5C72465D1FBFQ50049622-5A547887-4146-4A84-AA7C-5CA2A0D8D38CQ50055247-7B984A2B-9450-402F-ACDE-89A034018E66Q50105039-F33F78C0-1AB1-4DBC-9A59-923DBD1BFFACQ50223200-E4FCC391-18AD-4EBA-B819-2B960E6E6FCEQ50348976-9EAD1DE9-396B-4583-97B7-98AB556A570CQ52688574-459507C8-080D-4841-92B5-C50319C17780Q53512219-FECE3E20-40BB-4D0D-9FF1-1B0C1BEBDF77Q54972559-86AEA650-CB64-4B75-AF91-524FDAD7F152Q55128644-629EE541-B4ED-48E1-8671-D10456230ED5Q55220858-C8E22D0F-633E-4CBF-87F7-7FA2E8B5136FQ55312738-9703B133-9C33-4ABF-A861-6723BBB63B82Q55412795-2219E771-3104-4FDC-9217-9126401BE877Q58612356-8890AFFD-DA46-4EED-B6E0-20D63C395E1EQ58696706-B16A7D57-DD29-47D1-B26D-7392DFF0C444Q58787868-1A6FEBC0-5932-45EE-B6CF-1CB046625F5EQ59135014-C9E2066F-0422-4DAE-9AE8-6035ACC17B04
P2860
ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
ALS Clinical Trials Review: 20 ...... o Registering a New Treatment?
@ast
ALS Clinical Trials Review: 20 ...... o Registering a New Treatment?
@en
ALS Clinical Trials Review: 20 ...... o Registering a New Treatment?
@nl
type
label
ALS Clinical Trials Review: 20 ...... o Registering a New Treatment?
@ast
ALS Clinical Trials Review: 20 ...... o Registering a New Treatment?
@en
ALS Clinical Trials Review: 20 ...... o Registering a New Treatment?
@nl
prefLabel
ALS Clinical Trials Review: 20 ...... o Registering a New Treatment?
@ast
ALS Clinical Trials Review: 20 ...... o Registering a New Treatment?
@en
ALS Clinical Trials Review: 20 ...... o Registering a New Treatment?
@nl
P2093
P2860
P356
P1476
ALS Clinical Trials Review: 20 ...... o Registering a New Treatment?
@en
P2093
Alain Moussy
Colin Mansfield
Dmitry Petrov
P2860
P356
10.3389/FNAGI.2017.00068
P577
2017-03-22T00:00:00Z